BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
957 results:

  • 1. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
    Redmer T; Raigel M; Sternberg C; Ziegler R; Probst C; Lindner D; Aufinger A; Limberger T; Trachtova K; Kodajova P; Högler S; Schlederer M; Stoiber S; Oberhuber M; Bolis M; Neubauer HA; Miranda S; Tomberger M; Harbusch NS; Garces de Los Fayos Alonso I; Sternberg F; Moriggl R; Theurillat JP; Tichy B; Bystry V; Persson JL; Mathas S; Aberger F; Strobl B; Pospisilova S; Merkel O; Egger G; Lagger S; Kenner L
    Mol Cancer; 2024 May; 23(1):114. PubMed ID: 38811984
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
    Ruggeri E; Frezzato F; Mouawad N; Pizzi M; Scarmozzino F; Capasso G; Trimarco V; Quotti Tubi L; Cellini A; Cavarretta CA; Ruocco V; Serafin A; Angotzi F; Danesin N; Manni S; Facco M; Piazza F; Trentin L; Visentin A
    Front Immunol; 2024; 15():1393485. PubMed ID: 38807597
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.
    Gao Y; He H; Li X; Zhang L; Xu W; Feng R; Li W; Xiao Y; Liu X; Chen Y; Wang X; Bai B; Wu H; Cai Q; Li Z; Li J; Lin S; He Y; Ping L; Huang C; Mao J; Chen X; Zhao B; Huang H
    Signal Transduct Target Ther; 2024 May; 9(1):121. PubMed ID: 38755119
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression.
    Liao Y; Yan J; Beri NR; Giulino-Roth L; Cesarman E; Gewurz BE
    PLoS Pathog; 2024 Apr; 20(4):e1011939. PubMed ID: 38683861
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Curcumin Combined with Thalidomide Inhibits Proliferation of KG-1 Cells and Its Related Mechanisms].
    Liu J; Huang Y; Liu Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):422-427. PubMed ID: 38660846
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like lymphomas in mice.
    Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
    Suske T; Sorger H; Manhart G; Ruge F; Prutsch N; Zimmerman MW; Eder T; Abdallah DI; Maurer B; Wagner C; Schönefeldt S; Spirk K; Pichler A; Pemovska T; Schweicker C; Pölöske D; Hubanic E; Jungherz D; Müller TA; Aung MMK; Orlova A; Pham HTT; Zimmel K; Krausgruber T; Bock C; Müller M; Dahlhoff M; Boersma A; Rülicke T; Fleck R; de Araujo ED; Gunning PT; Aittokallio T; Mustjoki S; Sanda T; Hartmann S; Grebien F; Hoermann G; Haferlach T; Staber PB; Neubauer HA; Look AT; Herling M; Moriggl R
    J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618957
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1α.
    Incrocci R; Monroy Del Toro R; Devitt G; Salimian M; Braich K; Swanson-Mungerson M
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612754
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
    Chen Z; Huang H; Hong H; Huang H; Weng H; Yu L; Xiao J; Wang Z; Fang X; Yao Y; Yue JX; Lin T
    Genome Med; 2024 Apr; 16(1):48. PubMed ID: 38566223
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies.
    Daneshmandi S; Choi JE; Yan Q; MacDonald CR; Pandey M; Goruganthu M; Roberts N; Singh PK; Higashi RM; Lane AN; Fan TW; Wang J; McCarthy PL; Repasky EA; Mohammadpour H
    Nat Commun; 2024 Mar; 15(1):2803. PubMed ID: 38555305
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) inhibits proliferation and promotes apoptosis of human HEL cells with JAK2 V617F mutation by blocking the JAK/STAT and PI3K/AKT signaling pathways].
    Fan C; Zhang Y; Yang R; Wu X; Zhou J; Xue J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):207-214. PubMed ID: 38512030
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. stat3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.
    Prutsch N; He S; Berezovskaya A; Durbin AD; Dharia NV; Maher KA; Matthews JD; Hare L; Turner SD; Stegmaier K; Kenner L; Merkel O; Look AT; Abraham BJ; Zimmerman MW
    Cell Rep Med; 2024 Mar; 5(3):101472. PubMed ID: 38508140
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for stat3.
    Suo Y; Du D; Chen C; Zhu H; Wang X; Song N; Lu D; Yang Y; Li J; Wang J; Luo Z; Zhou B; Luo C; Zhou H
    J Med Chem; 2024 Mar; 67(6):4804-4818. PubMed ID: 38466231
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Indolent T-Cell/Natural Killer-Cell lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
    Wang XG; Yin WH; Wang HY
    Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines.
    Wu Y; Wang V; Yarchoan R
    Sci Rep; 2024 Feb; 14(1):4125. PubMed ID: 38374336
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP.
    Dhar S; Chakravarti M; Ganguly N; Saha A; Dasgupta S; Bera S; Sarkar A; Roy K; Das J; Bhuniya A; Ghosh S; Sarkar M; Hajra S; Banerjee S; Pal C; Saha B; Mukherjee KK; Baral R; Bose A
    Front Immunol; 2023; 14():1303959. PubMed ID: 38304256
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line.
    Rahmani R; Eivazi N; Emamgholipour S; Aminian M; Jalilian A; Paknejad M
    Mol Biol Rep; 2024 Feb; 51(1):250. PubMed ID: 38302816
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age.
    Seaton G; Smith H; Brancale A; Westwell AD; Clarkson R
    Mol Cancer; 2024 Jan; 23(1):7. PubMed ID: 38195591
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia.
    Wang F; Li Y; Yang Z; Cao W; Liu Y; Zhao L; Zhang T; Zhao C; Yu J; Yu J; Zhou J; Zhang X; Li PP; Han M; Feng S; Ng BW; Hu ZW; Jiang E; Li K; Cui B
    Nat Commun; 2024 Jan; 15(1):203. PubMed ID: 38172124
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan.
    Chen BJ; Hsieh TH; Yuan CT; Wang RC; Yang CF; Chuang WY; Su YZ; Ho CH; Lin CH; Chuang SS
    Pathol Res Pract; 2024 Jan; 253():155059. PubMed ID: 38160484
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 48.